140 related articles for article (PubMed ID: 37231961)
21. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
Boguszewski MCS; Boguszewski CL; Chemaitilly W; Cohen LE; Gebauer J; Higham C; Hoffman AR; Polak M; Yuen KCJ; Alos N; Antal Z; Bidlingmaier M; Biller BMK; Brabant G; Choong CSY; Cianfarani S; Clayton PE; Coutant R; Cardoso-Demartini AA; Fernandez A; Grimberg A; Guðmundsson K; Guevara-Aguirre J; Ho KKY; Horikawa R; Isidori AM; Jørgensen JOL; Kamenicky P; Karavitaki N; Kopchick JJ; Lodish M; Luo X; McCormack AI; Meacham L; Melmed S; Mostoufi Moab S; Müller HL; Neggers SJCMM; Aguiar Oliveira MH; Ozono K; Pennisi PA; Popovic V; Radovick S; Savendahl L; Touraine P; van Santen HM; Johannsson G
Eur J Endocrinol; 2022 Apr; 186(6):P35-P52. PubMed ID: 35319491
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.
Verweij T; Slagboom TNA; van Varsseveld NC; van der Lely AJ; Drent ML; van Bunderen CC
Eur J Endocrinol; 2021 Oct; 185(6):793-801. PubMed ID: 34605771
[TBL] [Abstract][Full Text] [Related]
23. Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls.
Postma MR; van Beek AP; Jönsson PJ; van Bunderen CC; Drent ML; Mattsson AF; Camacho-Hubner C
Neuroendocrinology; 2019; 109(2):131-140. PubMed ID: 30844796
[TBL] [Abstract][Full Text] [Related]
24. Effect of growth hormone treatment in children with craniopharyngioma with reference to the KIGS (Kabi International Growth Study) database.
Price DA; Jönsson P
Acta Paediatr Suppl; 1996 Oct; 417():83-5. PubMed ID: 9055921
[TBL] [Abstract][Full Text] [Related]
25. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
Holmer H; Ekman B; Björk J; Nordstöm CH; Popovic V; Siversson A; Erfurth EM
Eur J Endocrinol; 2009 Nov; 161(5):671-9. PubMed ID: 19667040
[TBL] [Abstract][Full Text] [Related]
26. Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.
Biscotto IP; Costa Hong VA; Batista RL; Mendonca BB; Arnhold IJP; Bortolotto LA; Carvalho LRS
Pituitary; 2021 Apr; 24(2):216-228. PubMed ID: 33098037
[TBL] [Abstract][Full Text] [Related]
27. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
[TBL] [Abstract][Full Text] [Related]
29. Growth Hormone Replacement Therapy Seems to Be Safe in Children with Low-Grade Midline Glioma: A Series of 124 Cases with Review of the Literature.
Puvilland C; Villanueva C; Hemmendinger A; Kornreich L; Gueorguieva I; Karnoub MA; Beuriat PA; Leblond P
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612052
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone deficiency and pregnancy: any role for substitution?
Vila G; Luger A
Minerva Endocrinol; 2018 Dec; 43(4):451-457. PubMed ID: 29521487
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy outcomes in women with growth hormone deficiency.
Vila G; Akerblad AC; Mattsson AF; Riedl M; Webb SM; Hána V; Nielsen EH; Biller BM; Luger A
Fertil Steril; 2015 Nov; 104(5):1210-7.e1. PubMed ID: 26256649
[TBL] [Abstract][Full Text] [Related]
32. Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation.
Gleeson H; Barreto ES; Salvatori R; Costa L; Oliveira CR; Pereira RM; Clayton P; Aguiar-Oliveira MH
Clin Endocrinol (Oxf); 2007 Apr; 66(4):466-74. PubMed ID: 17371461
[TBL] [Abstract][Full Text] [Related]
33. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
Cannavò S; Marini F; Trimarchi F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
[TBL] [Abstract][Full Text] [Related]
34. Hypopituitarism oddities: craniopharyngiomas.
Karavitaki N
Horm Res; 2007; 68 Suppl 5():151-3. PubMed ID: 18174734
[TBL] [Abstract][Full Text] [Related]
35. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
[TBL] [Abstract][Full Text] [Related]
36. Metabolic and quality of life effects of growth hormone replacement in patients with TBI and AGHD: A pilot study.
Herodes M; Le N; Anderson LJ; Migula D; Miranda G; Paulsen L; Garcia JM
Growth Horm IGF Res; 2023 Aug; 71():101544. PubMed ID: 37295336
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone deficiency and replacement therapy in adults: Impact on survival.
van Bunderen CC; Olsson DS
Rev Endocr Metab Disord; 2021 Mar; 22(1):125-133. PubMed ID: 33068227
[TBL] [Abstract][Full Text] [Related]
38. Adherence, Attitudes and Beliefs of Growth Hormone Deficient Patients - A Questionnaire-based Cohort Study.
Amereller F; Schilbach K; Schopohl J; Störmann S
Exp Clin Endocrinol Diabetes; 2021 Feb; 129(2):112-117. PubMed ID: 31266067
[TBL] [Abstract][Full Text] [Related]
39. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL
Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824
[TBL] [Abstract][Full Text] [Related]
40. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy.
Riedl M; Ludvik B; Pacini G; Clodi M; Kotzmann H; Wagner O; Kautzky-Willer A; Prager R; Luger A
Eur J Clin Invest; 2000 Sep; 30(9):771-8. PubMed ID: 10998076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
